Health Sciences Acquisitions Corporation

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors
    IPO Size
    $100M
    Focus
    Biopharma & medical technology in North America or Europe
    SEC Filings
    1764013
    IPO Ticker
    HSAC

    SPAC Leadership

    Information on the SPAC leadership.

    Target Information

    Information on the SPAC target for merger.

    Company
    Immunovant
    New Ticker
    IMVTHSACUHSACW

    Timeline